Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Marcus A Conant"'
Autor:
Kathryn A Mesa, Bin Yu, Terri Wrin, Christos J Petropoulos, Grant H Pogson, David L Alexander, Gerardo Perez, Sara M O'Rourke, Faruk Sinangil, Joseph Robinson, Marcus A Conant, Phillip W Berman
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0213409 (2019)
A major challenge in HIV vaccine development is the identification of immunogens able to elicit broadly neutralizing antibodies (bNAbs). While remarkable progress has been made in the isolation and characterization of bNAbs, the epitopes they recogni
Externí odkaz:
https://doaj.org/article/0e10722cf3d44aa2bd12c97c8f7b22f2
Autor:
Anshika Jain, Gaspar E. Canepa, Mei-Ling Liou, Emily L. Fledderman, Andrei I. Chapoval, Lingzhi Xiao, Ipsita Mukherjee, Bushirat M. Balogun, Hellen Huaman-Vergara, Jeffrey A. Galvin, Princy N. Kumar, José Bordon, Marcus A. Conant, Jefferey S. Boyle
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Human Immunodeficiency Virus (HIV) remains a global health challenge, and novel approaches to improve HIV control are significantly important. The cell and gene therapy product AGT103-T was previously evaluated (NCT04561258) for safety, immunogenicit
Externí odkaz:
https://doaj.org/article/20e27262bdc947c882faadf853294a85
Autor:
Terri Wrin, Faruk Sinangil, Marcus A. Conant, Bin Yu, Christos J. Petropoulos, Kathryn A. Mesa, Sara M. O'Rourke, David L. Alexander, Joseph Robinson, Gerardo Perez, Phillip W. Berman, Grant H. Pogson
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0213409 (2019)
A major challenge in HIV vaccine development is the identification of immunogens able to elicit broadly neutralizing antibodies (bNAbs). While remarkable progress has been made in the isolation and characterization of bNAbs, the epitopes they recogni
Autor:
David B. Sarwer, Tanyaporn Wansom, Marcus A. Conant, I-Chan Huang, Albert W. Wu, Joseph Cofrancesco
Publikováno v:
Aesthetic Surgery Journal. 36:842-851
Background Facial lipoatrophy is common in people on antiretroviral (ARV) regimens for HIV/AIDS and can impair health-related quality of life. Objectives We developed the Facial Appearance Inventory (FAI) to measure the impact of ARV-associated facia
Publikováno v:
International Journal of STD & AIDS. 17:429-435
Facial lipoatrophy can be associated with human immunodeficiency virus (HIV), impacting severely on quality of life. Various treatments have been investigated, including poly-L-lactic acid (PLLA). Four studies have investigated the efficacy of PLLA i
Publikováno v:
International Journal of Dermatology. 41:810-816
Imiquimod, the first member of a new class of immune response modifiers, is approved for the treatment of external genital and perianal warts. The clinical effect of imiquimod stems from cytokine-induced activation of the immune system. Topical appli
Autor:
Susan Hunt, Calvin J. Cohen, Jeffrey P. Nadler, Allan Stein, Martin Markowitz, Neil M.H. Graham, Douglas L. Mayers, Steven Davis, Shannon Schrader, W. Keith Henry, Charles Farthing, Michael Sension, Stephen Brown, Werner Verbiest, Kurt Hertogs, Deborah Copeland, Harold A. Kessler, Richard Stryker, Melanie A. Thompson, Michael S. Saag, Michael H. Ames, Carol L. Brosgart, Gabriel Torres, Susan Jacobson, Jeffrey Goodgame, Howard Grossman, Marcus A. Conant, Ann C. Collier, Alex R. Rinehart, Jeffrey Galpin, Roberto C. Arduino
Publikováno v:
AIDS. 16:579-588
Objective To compare the effect of treatment decisions guided by phenotypic resistance testing (PRT) or standard of care (SOC) on short-term virological response. Design A prospective, randomized, controlled clinical trial conducted in 25 university